glp-1 news nov 2025 November in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity How to Invest in GLP-1

Therapeutic effects of Glp-1 receptor agonists and Dpp-4 inhibitors in neuropathic pain: mechanisms and clinical implications

Key Takeaway Weight loss plateaus on semaglutide or tirzepatide are expected, evidence-based, and driven by normal metabolic physiology

Your stool should be clear and yellow, with no solid particles in it

Glinides allow minimal dose titration and have an immediate onset of action and short duration of effect, which adapts to the hyperglycaemic profile of the corticosteroids and reduces the risk of hypoglycemia in the morning, coinciding with the disappearance of the hyperglycemic action of corticosteroids[25]

TNF: tumor necrosis factor-alpha